Former brand name for the acetylcholinesterase inhibitor drug galantamine. In 2005, in response to reports of prescribing errors (resulting in two deaths) arising from the name’s similarity to the diabetic drug amaryl, the manufacturer began marketing reminyl under a new product name, razadyne.